Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,085
archived clinical trials in
Cervical Cancer

Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer
A Phase 2 Study of Oral ENMD-2076 Administered to Patients With Platinum Resistant Ovarian Cancer
Status: Enrolling
Updated:  8/4/2014
Indiana University Simon Cancer Center
mi
from
Indianapolis, IN
Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer
A Phase 2 Study of Oral ENMD-2076 Administered to Patients With Platinum Resistant Ovarian Cancer
Status: Enrolling
Updated: 8/4/2014
Indiana University Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer
A Phase 2 Study of Oral ENMD-2076 Administered to Patients With Platinum Resistant Ovarian Cancer
Status: Enrolling
Updated:  8/4/2014
Dana Farber/Partners Cancer Care
mi
from
Boston, MA
Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer
A Phase 2 Study of Oral ENMD-2076 Administered to Patients With Platinum Resistant Ovarian Cancer
Status: Enrolling
Updated: 8/4/2014
Dana Farber/Partners Cancer Care
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer
A Phase 2 Study of Oral ENMD-2076 Administered to Patients With Platinum Resistant Ovarian Cancer
Status: Enrolling
Updated:  8/4/2014
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer
A Phase 2 Study of Oral ENMD-2076 Administered to Patients With Platinum Resistant Ovarian Cancer
Status: Enrolling
Updated: 8/4/2014
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer
A Phase 2 Study of Oral ENMD-2076 Administered to Patients With Platinum Resistant Ovarian Cancer
Status: Enrolling
Updated:  8/4/2014
Princess Margaret Hospital
mi
from
Toronto,
Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer
A Phase 2 Study of Oral ENMD-2076 Administered to Patients With Platinum Resistant Ovarian Cancer
Status: Enrolling
Updated: 8/4/2014
Princess Margaret Hospital
mi
from
Toronto,
Click here to add this to my saved trials
SmartScope vs Standard Colposcope for the Evaluation of Cervical Dysplasia
Image Comparison of a Mobile Colposcope (SmartScope) vs. a Standard Colposcope for Directing Cervical Biopsies in Women With Abnormal Pap Smears: A Non-inferiority Trial.
Status: Enrolling
Updated:  10/21/2014
Scripps Clinic
mi
from
San Diego, CA
SmartScope vs Standard Colposcope for the Evaluation of Cervical Dysplasia
Image Comparison of a Mobile Colposcope (SmartScope) vs. a Standard Colposcope for Directing Cervical Biopsies in Women With Abnormal Pap Smears: A Non-inferiority Trial.
Status: Enrolling
Updated: 10/21/2014
Scripps Clinic
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Birmingham, AL
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Beverly Hills, CA
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Glendale, CA
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
San Francisco, CA
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Golden, CO
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Golden, CO
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Fort Myers, FL
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Miami, FL
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Tamarac, FL
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Tamarac, FL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Tampa, FL
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Atlanta, GA
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Chicago, IL
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Chicago, IL
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Ellsworth, ME
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Ellsworth, ME
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Baltimore, MD
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Baltimore, MD
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Boston, MA
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Cambridge, MA
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Cambridge, MA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Detroit, MI
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Royal Oak, MI
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
St. Louis, MO
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Palisades Park, NJ
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Palisades Park, NJ
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
New York, NY
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
New York, NY
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
New York, NY
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Belmont, NC
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Belmont, NC
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Durham, NC
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Dublin, OH
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Dublin, OH
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Portland, OR
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Arlington, TX
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Austin, TX
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Dallas, TX
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Houston, TX
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Houston, TX
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
McAllen, TX
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
McAllen, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
San Antonio, TX
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Temple, TX
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Temple, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Norfolk, VA
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Richmond, VA
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated:  1/29/2015
Clinical Research Facility
mi
from
Morgantown, WV
Efficacy and Safety of Adalimumab in Subjects With Inactive Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Inactive Non-infectious Intermediate, Posterior, or Pan-Uveitis
Status: Enrolling
Updated: 1/29/2015
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
A Phase I/II Study of Gleevec/Taxol in Patients With Newly Diagnosed Stage IIIC or IV or Recurrent (Any Stage) Uterine Papillary Serous Carcinoma (UPSC)
Status: Enrolling
Updated:  4/13/2015
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
A Phase I/II Study of Gleevec/Taxol in Patients With Newly Diagnosed Stage IIIC or IV or Recurrent (Any Stage) Uterine Papillary Serous Carcinoma (UPSC)
Status: Enrolling
Updated: 4/13/2015
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials